Skip to main content
Caplight Logo









Opmed.ai

Opmed.ai

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.opmed.ai/

Last Round

Series A

May 6, 2024

Total Funding Raised

$15.1M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Opmed.ai is a healthcare technology company that provides an AI-powered optimization platform designed to enhance operating room scheduling, resource allocation, and operational efficiency for hospitals.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

operating room managementsurgical schedulingOR optimizationhealthcare AIpredictive analyticsvertical SaaSperioperative workflowresource utilizationEHR integrationhospital operationsOR efficiencyAI schedulingsurgical throughputhealthcare staffingOR management software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Opmed.ai Comparables

Compare Opmed.ai with similar companies based on industry and business-model similarity.

Opmed.ai comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Apella Technology
89%
Qventus
79%
Oracle Corporation
72%

Opmed.ai Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 6, 2024
Pre SeedJun 1, 2020

Key People

Founding team and executive leadership

Avi Paz

Co-Founder & CTO

Founding Team

Mor Brokman

Co-Founder & CEO

Founding Team

Opmed.ai Investors

Notable investors and investment history

Opmed.ai investors
InvestorRounds
NFXSeries A
Unbox VenturesSeries A, Pre Seed
Grove VenturesSeries A
Secret Chord VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 174% MoM, reaching 7.6K.

  • Mar 1, 2026

    Geisinger is now a customer using the platform.

Opmed.ai Filings

Explore SEC and related filing metadata, where available.

Opmed.ai filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Opmed.ai's valuation, stock price, and market status.

Is Opmed.ai a public or private company?

Opmed.ai is a private company.

What is the current stock price of Opmed.ai?

Opmed.ai is a private company with no public stock price. No recent secondary market data is available.

How much is Opmed.ai worth (valuation)?

Valuation information for Opmed.ai is not publicly available.

Can I buy Opmed.ai stock?

Opmed.ai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Opmed.ai's last funding round?

Opmed.ai's most recent funding round was Series A on May 6, 2024.

Who are the main investors in Opmed.ai?

Key investors in Opmed.ai include NFX, Grove Ventures.

Will Opmed.ai IPO soon?

No public IPO plans have been announced for Opmed.ai.

How can I track Opmed.ai secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Opmed.ai's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range53
Year Founded2020
Last FundingMay 6, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?